At AMCP, Koya Medical showcased the NILE Trial results: Dayspring device outperformed APCD in treating lymphedema, providing greater adherence and satisfaction.
Koya Medical Selected for Presentation at AMCP Conference Read More »
Provider status with Medi-Cal will allow Mindera Health to provide its proprietary Mind.Px test to predict biologic class response in plaque psoriasis to the over 15 million Medi-Cal Beneficiaries. San Diego, CA, Aug 19, 2024 (GLOBE NEWSWIRE) — Mindera Health, developer of Mind.Px™, the first realization of precision medicine in psoriasis, has completed the credentialling
Mindera Health™ becomes a Medi-Cal™ Credentialled Provider Read More »
Lucas is an Industry veteran who brings expertise in commercialization, operations, business development, and finance to Procyrion as it continues to focus on its DRAIN-HF pivotal IDE trial and begins preparation for US commercialization of its Aortix percutaneous mechanical circulatory support (pMCS) technology.
Procyrion Announces Appointment of Lucas Buchanan to Board of Directors Read More »
Eirion to Present Update on Its Neuromodulator Product Candidates at The Medical Aesthetic Injectable Summit 2024October 1, 2024 – Woburn, MA – Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced today that successful results had been achieved in its Phase 1 – 2 clinical trial for the treatment of
Koya Medical announces positive interim results from randomized controlled study of Dayspring active compression treatment for lymphedema and venous disease.
Positive Interim Results for Dayspring Lymphedema Treatment Read More »
Koya Medical presented two clinical studies at AVLS showcasing improvements in lymphedema and venous disease outcomes with Dayspring active compression.
Koya Medical Presents Clinical Studies on Dayspring at AVLS Read More »
David G. Armstrong, DPM, MD, PhD; Gary M. Rothenberg, DPM, CDCES, CWS DISCLOSURES | October 18, 2024 What if teams of specialists from primary care, podiatry, endocrinology, infectious disease, vascular surgery, behavioral health, and other disciplines as needed routinely met as a “limb preservation board” or a “high-risk limb board” to discuss their shared patients, identify risks,
Can Diabetes Care Teams Improve Patient Outcomes and Value? Read More »
Podimetrics’ survey of 1,001 Medicaid beneficiaries with type 2 diabetes reveals that 65% face chronic behavioral health challenges, impacting their diabetes care. Depression and anxiety disrupt medication adherence and more. Findings highlight the urgent need for integrated mental and physical health support and demand for innovative tools.
In this episode of Becker’s Healthcare Podcast, Jon Bloom, CEO and co-founder of Podimetrics, shares how technology is transforming diabetes care. He highlights the vital role of patient engagement and adherence, the challenges of managing diabetes in underserved populations, and Podimetrics’ innovative solutions to improve outcomes for patients, payers, and providers.